Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,868 | -8,296 | -24,745 | -17,133 | -10,795 |
| Accounts payable and accrued liabilities | 2,413 | 484 | N/A | 426 | 207 |
| Other Working Capital | 5,026 | 2,363 | 2,572 | 651 | 95 |
| Other Operating Activity | -491 | 202 | 548 | -58 | 18 |
| Operating Cash Flow | $-7,921 | $-5,248 | $-21,625 | $-16,113 | $-10,475 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,500 | 4,500 | N/A | N/A | N/A |
| Other Financing Activity | -186 | -143 | 4,135 | 4,135 | 4,135 |
| Financing Cash Flow | $5,314 | $4,357 | $4,135 | $4,135 | $4,135 |
| Beginning Cash Position | 2,959 | 2,959 | 20,449 | 20,449 | 20,449 |
| End Cash Position | 352 | 2,068 | 2,959 | 8,471 | 14,109 |
| Net Cash Flow | $-2,607 | $-890 | $-17,491 | $-11,979 | $-6,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,921 | -5,248 | -21,625 | -16,113 | -10,475 |
| Free Cash Flow | -7,921 | -5,248 | -21,625 | -16,113 | -10,475 |